cyclosporine has been researched along with Bilirubinemia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bow, DA; Chiou, WJ; de Morais, SM; Kikuchi, R; Li, X; Voorman, RL | 1 |
| Asano, T; Ishii, E; Kanegane, H; Kogawa, K; Kudo, K; Morimoto, A; Oda, M; Ohga, S; Ohta, S; Sato, H; Wakiguchi, H | 1 |
| Abe, F; Hasegawa, T; Hayashi, T; Kato, M; Kimata, A; Nadai, M; Noguchi, H; Saito, H; Takeyama, N; Ueyama, J | 1 |
| Fukuda, H; Fukuyama, Y; Nakanishi, T; Shibue, Y; Shirasaka, Y; Tamai, I; Yoshida, K | 1 |
| Aricò, M; Berglöf, E; Beutel, K; Henter, JI; Horne, A; Janka, G; Lehmberg, K; Onelöv, E; Sieni, E; Silfverberg, T; Trottestam, H | 1 |
| Jih, MH; Kimyai-Asadi, A | 1 |
| Albitar, M; Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, F; Kantarjian, H; Keating, M; O'Brien, S; Thomas, D; Tsimberidou, A; Verstovsek, S | 1 |
| Asakura, E; Baba, K; Hasegawa, T; Kitaichi, K; Nadai, M; Sugie, M; Takagi, K; Torita, S; Zhao, YL | 1 |
| Dufour, C; Lanciotti, M; Nobili, B; Perrotta, S; Svahn, J | 1 |
| Fujiwara, M; Hori, A; Kami, M; Kanda, Y; Komatsu, T; Koyama, R; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Seki, K; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K | 1 |
| Bein, G; Bonkovsky, HL; Immenschuh, S; Kroll, H; Santoso, S; Shan, Y; Wössmann, W | 1 |
| Currin, RT; Lemasters, JJ; Theruvath, TP; Waldmeier, PC; Zhong, Z | 1 |
| Ertörer, ME; Paydaş, S; Sagliker, Y | 1 |
| Almogy, N; Fiodorov, D; Nakache, R; Weinbroum, A | 1 |
| Mai, I; Mergenthaler, HG; Naujokat, C; Possinger, K; Schweigert, M; Sezer, O | 1 |
| Chueh, SC; Huang, CY; Lai, MK | 1 |
| Modéer, T; Németh, A; Wondimu, B | 1 |
| Black, DL; Bluhm, RE; Branch, R; Rodgers, WH; Wilkinson, GR | 1 |
2 trial(s) available for cyclosporine and Bilirubinemia
| Article | Year |
|---|---|
Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Topics: Adrenal Cortex Hormones; Age of Onset; Antineoplastic Agents, Phytogenic; Asian People; Bilirubin; Child; Child, Preschool; Cyclosporine; Data Collection; Disease-Free Survival; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Infant; Japan; Lymphohistiocytosis, Hemophagocytic; Remission Induction; Retrospective Studies; Survival Rate | 2014 |
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.
Topics: Adult; Aged; Alanine Transaminase; Aminoglycosides; Anemia, Refractory, with Excess of Blasts; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Cyclosporine; Cytarabine; Female; Gemtuzumab; Humans; Hyperbilirubinemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Survival; Treatment Outcome; Vidarabine | 2003 |
16 other study(ies) available for cyclosporine and Bilirubinemia
| Article | Year |
|---|---|
In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia.
Topics: Antirheumatic Agents; Atazanavir Sulfate; Bilirubin; Carbamates; Cyclosporine; Furans; Glucuronosyltransferase; HIV Protease Inhibitors; Hyperbilirubinemia; In Vitro Techniques; Indinavir; Liver-Specific Organic Anion Transporter 1; Oligopeptides; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pyridines; Rifampin; Rifamycins; Saquinavir; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides | 2014 |
Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
Topics: Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Bile; Biological Transport; Cyclosporine; Echinocandins; Enzyme Inhibitors; Hyperbilirubinemia; Injections, Intravenous; Lipopeptides; Lipoproteins; Male; Micafungin; Rats; Rats, Sprague-Dawley | 2008 |
Quantitative time-lapse imaging-based analysis of drug-drug interaction mediated by hepatobiliary transporter, multidrug resistance-associated protein 2, in sandwich-cultured rat hepatocytes.
Topics: Animals; ATP-Binding Cassette Transporters; Bile Canaliculi; Cell Culture Techniques; Cell Membrane; Cells, Cultured; Cyclosporine; Drug Interactions; Fluoresceins; Fluorescent Dyes; Hepatocytes; Hyperbilirubinemia; Male; Microscopy, Fluorescence; Molecular Imaging; Pharmaceutical Preparations; Propionates; Quinolines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Rifampin | 2011 |
Risk factors for early death in children with haemophagocytic lymphohistiocytosis.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Ferritins; Fever; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Leukocytosis; Lymphohistiocytosis, Hemophagocytic; Male; Prognosis; Proportional Hazards Models; Risk Factors; Thrombocytopenia | 2012 |
Indirect hyperbilirubinemia caused by cyclosporine.
Topics: Adult; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Female; Humans; Hyperbilirubinemia | 2002 |
Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Bile; Cyclosporine; Erythromycin; Hyperbilirubinemia; Immunosuppressive Agents; Intestinal Mucosa; Kidney; Liver; Male; Mitochondrial Proteins; Probenecid; Rats; Rats, Sprague-Dawley; Rats, Wistar; Renal Agents; Ribosomal Proteins; Saccharomyces cerevisiae Proteins; Tissue Distribution | 2004 |
Gilbert syndrome as differential diagnosis of hyperbilirubinemia in acquired aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Child, Preschool; Cyclosporine; Diagnosis, Differential; Gilbert Disease; Humans; Hyperbilirubinemia; Male | 2005 |
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Busulfan; Chemical and Drug Induced Liver Injury; Cholangitis; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Diseases; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Incidence; Infant, Newborn; Liver Diseases; Liver Function Tests; Male; Melphalan; Middle Aged; Postoperative Complications; Risk Factors; Tacrolimus; Tissue Donors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2006 |
Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia.
Topics: Adolescent; Anemia, Hemolytic, Autoimmune; Cyclosporine; Genotype; Heme Oxygenase-1; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Male; Microsatellite Repeats; Polymorphism, Genetic; Splenectomy; Treatment Outcome | 2007 |
NIM811, a mitochondrial permeability transition inhibitor, prevents mitochondrial depolarization in small-for-size rat liver grafts.
Topics: Animals; Apoptosis; Cyclosporine; Electrophysiology; Graft Rejection; Hepatocytes; Hyperbilirubinemia; Ion Channels; Liver Regeneration; Liver Transplantation; Male; Mitochondria, Liver; Mitochondrial Proteins; Necrosis; Organ Size; Permeability; Rats; Rats, Inbred Lew; Uncoupling Protein 2 | 2007 |
Hyperbilirubinemia in a renal transplant patient due to cyclosporin A therapy.
Topics: Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Cyclosporine; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged | 1997 |
Vasoactive effect of cyclosporine on the rat peribiliary capillary plexus: relationship with cholestasis and hyperbilirubinemia.
Topics: Animals; Capillaries; Cholestasis; Cyclosporine; Hyperbilirubinemia; Immunosuppressive Agents; In Vitro Techniques; Liver; Rats; Vasoconstriction | 1997 |
In vitro and in vivo correlation of cyclosporin A-induced apoptosis in acute lymphoblastic leukemia.
Topics: Adolescent; Apoptosis; Cyclosporine; Dose-Response Relationship, Drug; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Leukocyte Count; Nausea; Paresthesia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1999 |
Mycophenolate mofetil-induced hyperbilirubinemia in renal transplant recipients.
Topics: Adult; Antilymphocyte Serum; Bilirubin; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 2000 |
Oral health in liver transplant children administered cyclosporin A or tacrolimus.
Topics: Adolescent; Adult; Biliary Atresia; Child; Child, Preschool; Cyclosporine; Dental Enamel; Dental Enamel Hypoplasia; Dental Plaque Index; DMF Index; Female; Follow-Up Studies; Gingival Overgrowth; Gingivitis; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Liver Transplantation; Male; Mouth Diseases; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Statistics as Topic; Statistics, Nonparametric; Tacrolimus; Tooth Discoloration; Tooth Diseases | 2001 |
Cholestasis in transplant patients--what is the role of cyclosporin?
Topics: Adolescent; Adult; Alkaline Phosphatase; Anti-Bacterial Agents; Aspartate Aminotransferases; Bilirubin; Biopsy; Child; Child, Preschool; Cholestasis; Chromatography, High Pressure Liquid; Creatinine; Cross Reactions; Cyclosporine; Female; Fluorescence Polarization Immunoassay; Humans; Hyperbilirubinemia; Infant; L-Lactate Dehydrogenase; Liver; Male; Prognosis; Time Factors; Transplantation | 1992 |